Exagen Inc

Research Exagen Inc (XGN) on Bullrun: market cap USD 114.76M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerXGN
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Market capUSD 114.76M
• Financial periodFY2025
• RevenueUSD 66.58M
• Revenue growth19.7%
• Net income-USD 19.95M
• Free cash flow-USD 14.27M
• Gross margin58.3%

Valuation Snapshot

latest market cap is USD 114.76M.

About Exagen Inc

Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of complex rheumatic, and autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).

Frequently asked questions

What is Exagen Inc's market cap?

Exagen Inc's market capitalization is USD 114.76M.

What does Exagen Inc do?

Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of complex rheumatic, and autoimmune and autoimmune-related diseases,...